483
Cantor BioConnect, Inc.FDA 483 - Cantor BioConnect, Inc. - March 24, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Cantor BioConnect, Inc., a blood component storage and distribution facility in Santee, CA, received a Form 483 with two observations. The inspection revealed deficiencies in the firm's complaint handling system for distributed biological products and a failure to conduct preventive maintenance on -20°C freezers according to manufacturer specifications. These issues indicate a need for improved quality system procedures and equipment management.
Open in Dashboard
ID · e5bef515-4b21-4dc3-9eba-004df0a7a897